Correlation Between Kulicke and Lipocine
Can any of the company-specific risk be diversified away by investing in both Kulicke and Lipocine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kulicke and Lipocine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kulicke and Soffa and Lipocine, you can compare the effects of market volatilities on Kulicke and Lipocine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kulicke with a short position of Lipocine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kulicke and Lipocine.
Diversification Opportunities for Kulicke and Lipocine
Very good diversification
The 3 months correlation between Kulicke and Lipocine is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Kulicke and Soffa and Lipocine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipocine and Kulicke is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kulicke and Soffa are associated (or correlated) with Lipocine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipocine has no effect on the direction of Kulicke i.e., Kulicke and Lipocine go up and down completely randomly.
Pair Corralation between Kulicke and Lipocine
Given the investment horizon of 90 days Kulicke and Soffa is expected to under-perform the Lipocine. But the stock apears to be less risky and, when comparing its historical volatility, Kulicke and Soffa is 2.84 times less risky than Lipocine. The stock trades about -0.23 of its potential returns per unit of risk. The Lipocine is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest 526.00 in Lipocine on October 13, 2024 and sell it today you would lose (37.00) from holding Lipocine or give up 7.03% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Kulicke and Soffa vs. Lipocine
Performance |
Timeline |
Kulicke and Soffa |
Lipocine |
Kulicke and Lipocine Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Kulicke and Lipocine
The main advantage of trading using opposite Kulicke and Lipocine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kulicke position performs unexpectedly, Lipocine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipocine will offset losses from the drop in Lipocine's long position.Kulicke vs. Ultra Clean Holdings | Kulicke vs. Ichor Holdings | Kulicke vs. Entegris | Kulicke vs. Amtech Systems |
Lipocine vs. Reviva Pharmaceuticals Holdings | Lipocine vs. ZyVersa Therapeutics | Lipocine vs. Unicycive Therapeutics | Lipocine vs. Checkpoint Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
CEOs Directory Screen CEOs from public companies around the world | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Bonds Directory Find actively traded corporate debentures issued by US companies |